Biomerica (BMRA) Revenue (2010 - 2026)

Biomerica has disclosed Revenue across 17 years of filings, most recently posting $875000.0 for Q2 2026.

• In Q2 2026, Revenue rose 16.82% year-over-year to $875000.0; the TTM figure through May 2026 stood at $4.5 million (down 16.17% YoY), while the FY2026 annual figure was $4.5 million, down 16.16% from the prior year.
• Revenue came in at $875000.0 for Q2 2026 at Biomerica, down from $987000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.7 million in Q1 2022 to a low of $749000.0 in Q2 2025.
• Average Revenue over 5 years is $1.9 million, with a median of $1.3 million recorded in 2025.
• Year-over-year, Revenue surged 403.01% in 2022 and tumbled 85.5% in 2023.
• Over 5 years, Revenue stood at $1.5 million in 2022, then increased by 5.74% to $1.6 million in 2023, then gained by 4.4% to $1.6 million in 2024, then dropped by 26.04% to $1.2 million in 2025, then decreased by 27.69% to $875000.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $875000.0 in Q2 2026, $987000.0 in Q1 2026, and $1.2 million in Q4 2025.